What is Ductal Carcinoma in Situ (DCIS)?
Ductal carcinoma in situ (DCIS) is the earliest form of breast cancer where the abnormal cells are confined within the milk duct of the breast. DCIS is sometimes referred to as stage 0 cancer, non-invasive breast cancer, or pre-cancer; these terms all mean the same thing. DCIS is not life-threatening and prognosis is excellent, but having DCIS can increase the risk of developing an invasive breast cancer in the future.
Our Unique Approach to Treating DCIS
The Ductal Carcinoma in Situ (DCIS) Program at Dana-Farber Brigham Cancer Center is the only program in the Northeast dedicated to DCIS. Our program combines clinical care with in-depth research and educational resources to provide individualized care for each patient's unique situation. Our specialized team includes breast surgeons, radiation oncologists, and dedicated nurse practitioners and physician assistants who will review your treatment options and support your individual needs.